Please assess the completion status of the following clinical trial:

Trial Title: The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Males or females, aged between 50 and 75.~* Outpatients scheduled for screening or surveillance colonoscopy for polyps or colorectal cancer )~* Able to comprehend the full nature and purpose of the study, including possible risks and side effects.~* Able to co-operate with the investigator and to comply with the requirements of the entire study.~* Signed written informed consent prior to inclusion in the study.~Exclusion Criteria:~* Patients at high risk of colorectal cancer e.g. ulcerative colitis~* Previous medical history of, or suspected hypersensitivity to, the Methylene Blue and/or formulations' ingredients.~* Previous medical history of, or suspected hypersensitivity to, the PEG based bowel cleansing preparation and/or bowel cleansing formulations' ingredients.~* Previous medical history of gastrointestinal obstruction or perforation, toxic megacolon, major colonic resection, severe diverticulitis, heart failure (Class III or IV), serious cardiovascular disease, ulcerative colitis or Crohn's disease.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Methylene Blue MMX® 200mg (Type: ACTIVE_COMPARATOR): Oral dose, 8 Methylene Blue MMX® tablets over a 4hr schedule
- Methylene Blue MMX® 100mg (Type: ACTIVE_COMPARATOR): Oral dose, 4 Methylene Blue MMX® tablets and 4 Placebo tablets over a 4hr schedule
- Placebo (Type: PLACEBO_COMPARATOR): Oral dose, 8 Placebo tablets over a 4hr schedule

Based on this trial design, predict the completion outcome and termination type (if applicable).